Main > NEPHROLOGY > USA. A. aHUS>Treat.>RavulizuMAb Inj

---

USA. A. aHUS>Treat.>RavulizuMAb Inj's subsections
(*) EU CE Mark Date: 2020. 06.29
(*) JP Approval Date: 2020. 09.25
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 6
Patent>UpDate: 2021. 03.09.
TradeMark
TradeMark Web-Site

USA. A. aHUS>Treat.>RavulizuMAb Inj's products
This section has no products